Lawrence Lai
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 3
- Surgery 3
- Anesthesia and Pain Management 1
- Co-authors
- David A. Scheinberg (5 shared papers)Dangshe Ma (3 shared papers)Michael R. McDevitt (2 shared papers)Michael Curcio (2 shared papers)Neil H. Bander (2 shared papers)Paul E. Borchardt (1 shared paper)Matthias Miederer (1 shared paper)Jim Simón (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)Science (1 paper)Journal of Clinical Microbiology (1 paper)Leukemia (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesPuerto RicoDenmark
In The Last Decade
Lawrence Lai
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Radiology, Nuclear Medicine and Imaging 557
- Oncology 381
- Hematology 135
- Immunology 195
- Pulmonary and Respiratory Medicine 252
Countries citing papers authored by Lawrence Lai
This map shows the geographic impact of Lawrence Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Lai more than expected).
Fields of papers citing papers by Lawrence Lai
This network shows the impact of papers produced by Lawrence Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Lai. The network helps show where Lawrence Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 381 | |
| 2 | An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. | 2000 | 215 |
| 3 | 2000 | 195 | |
| 4 | 1995 | 105 | |
| 5 | 1995 | 78 | |
| 6 | Antitumor activity of actinonin in vitro and in vivo. | 1998 | 55 |
| 7 | 2012 | 39 | |
| 8 | 2002 | 39 | |
| 9 | Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia. | 1995 | 34 |
| 10 | 1997 | 23 | |
| 11 | 2009 | 22 | |
| 12 | 1993 | 2 |
About Lawrence Lai
Lawrence Lai is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Spine and Intervertebral Disc Pathology (1 paper), Diet, Metabolism, and Disease (1 paper), Cancer therapeutics and mechanisms (1 paper), Complement system in diseases (1 paper) and Anesthesia and Pain Management (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (557 citations), Oncology (381 citations), Hematology (135 citations), Immunology (195 citations) and Pulmonary and Respiratory Medicine (252 citations). Lawrence Lai has collaborated with scholars based in United States, Puerto Rico and Denmark. Frequent co-authors include David A. Scheinberg, Dangshe Ma, Michael R. McDevitt, Michael Curcio, Neil H. Bander, Paul E. Borchardt, Matthias Miederer, Jim Simón, R. Keith Frank and Karen Wu. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Science, Journal of Clinical Microbiology, Leukemia and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.